Denis Roy

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)

Nida Siddiqi, Christopher Neil, M F Bruce et al. · European Heart Journal · 2014 · 155 citations · Full text

Medicine, Cardiology, Pharmacology +13

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

Krystyna Tatarkiewicz, Pam Smith, Emmanuel J. Sablan et al. · American Journal of Physiology-Endocrinology and Metabolism · 2010 · 91 citations · Full text

Medicine, Endocrinology, Pharmacology +17

No evidence of drug‐induced pancreatitis in rats treated with exenatide for 13 weeks

Krystyna Tatarkiewicz, P M Bélanger, Gyo‐Jeong Gu et al. · Diabetes Obesity and Metabolism · 2012 · 56 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Occurrence of Spontaneous Pancreatic Lesions in Normal and Diabetic Rats: A Potential Confounding Factor in the Nonclinical Assessment of GLP-1–Based Therapies

Kristina D. Chadwick, Anthony M. Fletcher, M. Cecilia M. Parrula et al. · Diabetes · 2013 · 37 citations

Medicine, Endocrinology, Pathology +17